Namrata Bhutani, et al. “Targeted Therapy for CML Patients on Imatinib: Role of Novel Variants of Human Organic Cationic Transporter 1 (hOCT1)”. Disease and Health Research: New Insights Vol. 3, Aug. 2024, pp. 81-87, doi:10.9734/bpi/dhrni/v3/1656.